Sofia Pappa

5.8k total citations · 1 hit paper
65 papers, 3.7k citations indexed

About

Sofia Pappa is a scholar working on Psychiatry and Mental health, Clinical Psychology and Neurology. According to data from OpenAlex, Sofia Pappa has authored 65 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Psychiatry and Mental health, 21 papers in Clinical Psychology and 13 papers in Neurology. Recurrent topics in Sofia Pappa's work include Schizophrenia research and treatment (29 papers), COVID-19 and Mental Health (12 papers) and Mental Health and Psychiatry (9 papers). Sofia Pappa is often cited by papers focused on Schizophrenia research and treatment (29 papers), COVID-19 and Mental Health (12 papers) and Mental Health and Psychiatry (9 papers). Sofia Pappa collaborates with scholars based in United Kingdom, Greece and Spain. Sofia Pappa's co-authors include Paraskevi Κatsaounou, Vassilis G. Giannakoulis, Vasiliki Ntella, Eleni Papoutsi, Timoleon Giannakas, Paola Dazzan, Nikolaos Sakkas, Spiridon Konitsiotis, Sofia Tsouli and George Apostolou and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Psychological Medicine.

In The Last Decade

Sofia Pappa

61 papers receiving 3.6k citations

Hit Papers

Prevalence of depression, anxiety, and insomnia among hea... 2020 2026 2022 2024 2020 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Pappa United Kingdom 18 2.7k 1.7k 551 511 461 65 3.7k
Behnam Khaledi‐Paveh Iran 16 2.5k 1.0× 805 0.5× 441 0.8× 755 1.5× 271 0.6× 39 3.8k
Jianbo Hu China 12 4.6k 1.7× 2.9k 1.8× 605 1.1× 854 1.7× 325 0.7× 38 5.9k
Rima Styra Canada 16 2.2k 0.8× 760 0.5× 408 0.7× 601 1.2× 168 0.4× 42 3.4k
Lee Phan Canada 15 2.8k 1.1× 656 0.4× 477 0.9× 908 1.8× 316 0.7× 46 4.2k
Ning Wei China 18 5.0k 1.9× 3.0k 1.8× 958 1.7× 892 1.7× 488 1.1× 39 6.8k
Bin Fan United States 19 2.6k 1.0× 1.1k 0.7× 278 0.5× 521 1.0× 129 0.3× 32 3.1k
Yankun Sun China 14 2.5k 0.9× 769 0.5× 473 0.9× 633 1.2× 162 0.4× 25 3.5k
Timoleon Giannakas Greece 6 2.3k 0.9× 1.5k 0.9× 323 0.6× 434 0.8× 64 0.1× 8 2.8k
Gregory H. Cohen United States 23 2.0k 0.7× 834 0.5× 187 0.3× 657 1.3× 177 0.4× 74 3.7k

Countries citing papers authored by Sofia Pappa

Since Specialization
Citations

This map shows the geographic impact of Sofia Pappa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Pappa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Pappa more than expected).

Fields of papers citing papers by Sofia Pappa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Pappa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Pappa. The network helps show where Sofia Pappa may publish in the future.

Co-authorship network of co-authors of Sofia Pappa

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Pappa. A scholar is included among the top collaborators of Sofia Pappa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Pappa. Sofia Pappa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pappa, Sofia, et al.. (2025). Cariprazine and clozapine: a systematic review of a promising antipsychotic combination for treatment-resistant schizophrenia. The International Journal of Neuropsychopharmacology. 28(8).
3.
Pappa, Sofia, et al.. (2025). CLINICAL AND ECONOMIC BURDEN OF MAJOR AND TREATMENT- RESISTANT DEPRESSION IN A POPULATION-BASED STUDY COHORT OF 110.000 PATIENTS. The International Journal of Neuropsychopharmacology. 28(Supplement_1). i20–i20.
4.
Pappa, Sofia, et al.. (2024). Cariprazine in the management of emotionally unstable personality disorder in female patients: a case series. Frontiers in Psychiatry. 15. 1421698–1421698. 1 indexed citations
6.
Asimakos, Andreas, Stavroula Spetsioti, Spyros D. Mentzelopoulos, et al.. (2024). Rehabilitation Is Associated With Improvements in Post–COVID-19 Sequelae. Respiratory Care. 69(11). 1361–1370. 1 indexed citations
8.
García-Carmona, Juan Antonio & Sofia Pappa. (2023). Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal. Drug Healthcare and Patient Safety. Volume 15. 113–123. 1 indexed citations
9.
Pappa, Sofia, et al.. (2023). Switching from Monthly to Three-Monthly Long-Acting Injectable Paliperidone: A Survey on Subjective Satisfaction and Safety. Patient Preference and Adherence. Volume 17. 1603–1610. 7 indexed citations
10.
Pappa, Sofia, Nikolaos Athanasiou, Stavros Patrinos, et al.. (2022). Depression, Insomnia and Post-Traumatic Stress Disorder in COVID-19 Survivors: Role of Gender and Impact on Quality of Life. Journal of Personalized Medicine. 12(3). 486–486. 25 indexed citations
11.
Pappa, Sofia, Stylianos Gatzonis, Nikolaos Drakoulis, et al.. (2022). The Greek Collaborative Long COVID Study: Non-Hospitalized and Hospitalized Patients Share Similar Symptom Patterns. Journal of Personalized Medicine. 12(6). 987–987. 8 indexed citations
12.
Taylor, David, et al.. (2022). Dopamine partial agonists: a discrete class of antipsychotics. International Journal of Psychiatry in Clinical Practice. 27(3). 272–284. 8 indexed citations
13.
Thana, Lavanya, Abhishek Shastri, Verity C. Leeson, et al.. (2022). Barriers to the management of sexual dysfunction among people with psychosis: analysis of qualitative data from the REMEDY trial. BMC Psychiatry. 22(1). 545–545. 4 indexed citations
14.
Pappa, Sofia, Jiyao Chen, Rebecca Kechen Dong, et al.. (2021). A systematic review and meta‐analysis of the mental health symptoms during the Covid‐19 pandemic in S outheast A sia. Psychiatry and Clinical Neurosciences. 76(2). 41–50. 51 indexed citations
15.
Pappa, Sofia, Nikolaos Athanasiou, Nikolaos Sakkas, et al.. (2021). From Recession to Depression? Prevalence and Correlates of Depression, Anxiety, Traumatic Stress and Burnout in Healthcare Workers during the COVID-19 Pandemic in Greece: A Multi-Center, Cross-Sectional Study. International Journal of Environmental Research and Public Health. 18(5). 2390–2390. 65 indexed citations
16.
Puntis, Stephen, Daniel Whiting, Sofia Pappa, & Belinda Lennox. (2021). Development and external validation of an admission risk prediction model after treatment from early intervention in psychosis services. Translational Psychiatry. 11(1). 35–35. 11 indexed citations
17.
Pataka, Athanasia, et al.. (2021). Sleep Dysfunction in COVID-19 Patients: Prevalence, Risk Factors, Mechanisms, and Management. Journal of Personalized Medicine. 11(11). 1203–1203. 29 indexed citations
18.
O’Driscoll, Ciarán, et al.. (2021). Profiles and trajectories of mental health service utilisation during early intervention in psychosis. Schizophrenia Research. 237. 47–53. 3 indexed citations
19.
Crawford, Mike, Lavanya Thana, Rachel Evans, et al.. (2020). Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT. Health Technology Assessment. 24(44). 1–54. 8 indexed citations
20.
Hyphantis, Thomas, Sofia Pappa, Miltiadis Aspiotis, et al.. (2006). Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment. Journal of Psychosomatic Research. 61(5). 609–617. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026